U.S. Deer Antler Ex. & Imp., of Los Angeles, CA is recalling a variety of Herbal Teas prepared on premises between 4/1/17 and 4/30/17 in cooperation with an inspection made by the California Department of Public Health. The aforementioned Herbal Teas, especially those with low-acidity held at room temperature, were not produced according to approved guideline, making them susceptible to contamination by Clostridium botulinum.
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2q2uu9V
via IFTTT
Thursday, May 4, 2017
Physicians Report Sleep Apnea Infrequently in Older and Older Vulnerable Adults - American Geriatric Society
Objectives
To determine how often outpatient physician visits detect sleep apnea (SA) in older persons in the United States.
Design
Retrospective Analysis.
Setting
US non hospital and hospital based clinics.
Participants
US physicians.
Measurements
National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey data from 1993 to 2011 were used to assess the frequency of physicians' coding diagnoses of SA in persons aged 65 and older. Which specialties are most likely to report SA, the most-common comorbid conditions reported with SA, and the likelihood of reporting SA in patient visits for dementia and preoperative care were assessed.
Results
From 1993 to 2011, physicians reported SA in 0.3% of all office visits in persons aged 65 and older. SA reported in visits increased from 130,000 in 1993 to 2,070,000 in 2011, with an annual per capita visit reporting rate of 0.07% to 0.74%. In older populations, the proportion of documented SA visits by specialists rose, and that of primary care providers decreased. Older adults with a diagnosis of SA had higher average number of comorbidities than those without SA (1.8 vs 1.3). Reporting SA was low in visits with a diagnosis of dementia and classified as a preoperative visits.
Conclusion
In two nationwide surveys, SA reporting by physicians in elderly adults was 16 as greater in 2001 as in 1993, although reporting of SA remains infrequent (<1% of visits) even in vulnerable populations.
from Journal of the American Geriatrics Society http://ift.tt/2quEzMU
via IFTTT
Wednesday, May 3, 2017
Imported Frozen Raw Tuna (Ahi) Cubes Distributed on Oahu Test Positive for Hepatitis A; Voluntary Product Recall Underway - FDA Safety Alerts & Drug Recalls
The Hawaii State Department of Health (DOH) has been notified of imported frozen raw tuna or ahi cubes distributed by Tropic Fish Hawaii, LLC on Oahu that tested positive for hepatitis A. The product, imported from Indonesia, was used to prepare poke sold between April 27 – May 1 by food establishments on Oahu.
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2pae6jN
via IFTTT
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2pae6jN
via IFTTT
ReFlow Medical Issues Recall of Specific Lots of Wingman35 Crossing Catheters - FDA Safety Alerts & Drug Recalls
On April 22, 2017, ReFlow Medical initiated a lot-specific voluntary recall of the Wingman35 Crossing Catheters.
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2qFP8ZN
via IFTTT
from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2qFP8ZN
via IFTTT
Opioids and Other Central Nervous System–Active Polypharmacy in Older Adults in the United States - American Geriatric Society
Objectives
To determine patterns of and trends in contributions to central nervous system (CNS) polypharmacy, defined by the Beers Criteria as three or more CNS-active medications of each medication class, of adults aged 65 and older seen in U.S. outpatient medical practices.
Design
National Ambulatory Medical Care Survey (2004–2013).
Setting
U.S. outpatient medical care.
Participants
Visits by older adults to outpatient physicians (N = 97,910).
Measurements
Visits including three or more CNS medications including antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics (NBRAs), tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and opioids. The proportion of CNS polypharmacy that each medication class contributed during 2011 to 2013 was determined, and then logistic regression was used to determine trends from 2004 to 2013 in the contribution of individual medication classes to such polypharmacy.
Results
Of recent CNS polypharmacy visits, 76.2% included an opioid, and 61.8% included a benzodiazepine; 66.0% of the polypharmacy visits with benzodiazepines included opioids, and 53.3% of the polypharmacy visits with opioids included benzodiazepines. Between 2011 and 2013, opioid and benzodiazepine co-prescribing occurred at approximately 1.50 million visits (95% confidence interval (CI) = 1.23–1.78 million) annually. From 2004 (reference) to 2013, the proportion of polypharmacy visits with opioids rose from 69.6% to 76.2% (adjusted odds ratio = 2.15, 95% CI = 1.19–3.91, P = .01), and the corresponding proportion that included benzodiazepines fell. Of the polypharmacy visits, the odds of SSRI, NBRA, and antipsychotic use were unchanged, and that of TCAs decreased.
Conclusion
In older adults, opioid use appears to be largely driving the recent national increase in CNS polypharmacy. Although concomitant use of opioids and benzodiazepines is associated with greater mortality, they are the most common contributors to CNS polypharmacy in older adults.
from Journal of the American Geriatrics Society http://ift.tt/2qEyie7
via IFTTT
Latent Tuberculosis Infection Testing Practices in Long-Term Care Facilities, Boston, Massachusetts - American Geriatric Society
Objectives
To describe latent tuberculosis infection (LTBI) testing practices in long-term care facilities (LTCFs).
Design
Retrospective cohort study.
Setting
Three Boston-area LTCFs.
Participants
Residents admitted between January 1 and December 31, 2011.
Measurements
Resident demographic characteristics, comorbidities, LTCF stay, and LTBI testing and treatment.
Results
Data for 291 LTCF residents admitted in 2011 were reviewed. Of the 257 without a history of LTBI and with documentation of testing, 162 (63%) were tested; 114 of 186 (61%) with a stay less than 90 days and 48 of 71 (68%) with a stay of 90 days or longer were tested. Of 196 residents with data on prior LTBI testing, 39 (19.9%) had LTBI; 12 of these (30.8%) were diagnosed at the LTCF. Hispanic participants were more likely than black participants to undergo LTBI testing (adjusted odds ratio (aOR) = 2.4, P = .003). Having a length of stay of less than 90 days (aOR = 0.7, P < .001) and history of illicit drug use (aOR = 0.7, P < .001) were associated with lower odds of LTBI testing.
Conclusion
One-fifth of LTCF residents had LTBI, but testing was not always performed. The high prevalence of LTBI in older adults combined with the risk of an outbreak if a case of tuberculosis occurs in a LTCF make LTBI testing and treatment an important prevention opportunity. The importance of LTBI testing in LTCFs needs to be reinforced.
from Journal of the American Geriatrics Society http://ift.tt/2pHukEf
via IFTTT
Subscribe to:
Posts (Atom)